Statins and risk of polyneuropathy: A case-control study

Neurology

Volumn 58, Issue 9, 2002, Pages 1333-1337

  Gaist, David ^a   Jeppesen, U ^a   Andersen, M ^a   Garcia Rodriguez L A ^a   Hallas, J ^a   Sindrup, S H ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

STATINE DERIVATIVE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG EXPOSURE; DRUG SAFETY; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NERVOUS SYSTEM; POLYNEUROPATHY; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SECONDARY PREVENTION;

EID: 0037076488     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.9.1333     Document Type: Article

References (19)

1. Time trend analysis and variations in prescribing lipid-lowering drugs in general practice
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study
3. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
4. HMG-CoA reductase inhibitor therapy and peripheral neuropathy
5. Lovastatin and peripheral neuropathy
6. Peripheral neuropathy associated with simvastatin
7. Peripheral neuropathy and lipid-lowering therapy
8. Statins and peripheral neuropathy
9. Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?
10. Danish prescription registries
11. Neuropathy due to drugs
12. Expressing the magnitude of adverse effects in case-control studies: "The number of patients needed to be treated for one additional patient to be harmed"
13. Lovastatin 5-year safety and efficacy study
14. Neuropathy associated with hyperlipidemia
15. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK